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Everyday our bodies are exposed to reactive oxygen species as a byproduct of energy production. 
Reactive oxygen species (ROS) play various roles in normal cellular function, but when they accumulate
they lead to oxidative stress, which causes damage to the DNA, protein, and membrane lipids of a cell. This
damage can lead to a variety of diseases such as cancer, cardiovascular disease, and obesity.  Luckily, our
cells have a response to oxidative stress, which facilitates the removal of harmful ROS and promotes cell
survival.  Recently, many of the proteins, which make up this protective response, have been implicated in
promoting cancer when overexpressed.  One such protein, Heme Oxygenase-I (HMOX1), has been
implicated in promoting metastatic growth when overexpressed at later stages in development. This
dissertation provides evidence for a role for heme oxygenase activity in promoting melanoma
tumorigenesis.  Because metastatic melanoma has a median overall survival (OS) of only 6 to 10 months
and current therapeutic strategies provide only modest improvement in OS, there remains a need for the
identification and development of novel targeted therapies. Heme oxygenase activity may provide a novel
therapeutic target for the treatment of metastatic melanoma. 
